Related Experiment Videos
Clinical experience with ciprofloxacin: analysis of a multicenter study
Summary
Ciprofloxacin demonstrated significant efficacy in treating various infections, achieving high rates of bacteriologic and clinical cure in a multicenter study. While generally well-tolerated, one patient experienced severe vomiting, leading to treatment discontinuation.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic.
- Effective treatment of bacterial infections requires careful selection of antimicrobial agents.
- Multicenter studies are crucial for evaluating drug efficacy and safety across diverse patient populations.
Purpose of the Study:
- To evaluate the efficacy and safety of ciprofloxacin in treating a variety of infections.
- To assess bacteriologic and clinical outcomes in patients receiving ciprofloxacin therapy.
- To identify any adverse reactions associated with ciprofloxacin use.
Main Methods:
- A multicenter study involving 19 patients with various infections.
- Patients received ciprofloxacin at a mean daily dosage of 972 mg for a mean duration of 8.5 days.
- Ten infections were microbiologically proven, with outcomes assessed for bacteriologic and clinical cure and improvement.
Main Results:
- Bacteriologic cure was achieved in 70% of microbiologically proven infections, with 30% showing improvement.
- Overall clinical cure was observed in 73.7% of patients, with 15.8% showing improvement.
- One case of severe vomiting, deemed related to ciprofloxacin, led to treatment discontinuation.
Conclusions:
- Ciprofloxacin exhibits considerable efficacy in treating a range of bacterial infections.
- The antibiotic is generally well-tolerated, with a low incidence of serious adverse events.
- Further research may be warranted to explore ciprofloxacin's role in specific infection types.